News
The planned registration program consists of two double-blind, placebo-controlled multicenter ... with primary endpoints being liver biopsy and 4.5-year clinical outcomes. FASCINIT in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback